Positive prognosis: A growing older population and expansion into emerging markets will protect revenue

Over the five years to 2017, pharmaceutical manufacturers have benefited from an aging population in developed economies and a growing middle class in emerging economies, which provided a larger customer base for industry operators. Many manufacturers also tapped into regional demand for pharmaceuticals that may differ from developed markets, such as higher rates of gastric and esophageal cancer in East Asia. Furthermore, the growing global middle class provides additional growth opportunities, given increased access to pharmaceutical products and higher per capita expenditure on medicines. Over the five years to 2022, industry revenue is forecast to grow as more pharmaceutical manufacturers tailor their R&D and product portfolio to meet emerging markets' healthcare needs...purchase to read more.

Industry Statistics & Market Size
Annual Growth 12-17
Forecast Growth 17-22
Market Share of Companies
There are no companies with a dominant market share in this industry

Industry Threats & Opportunities

  • The industry will be challenged by key patent expirations and pricing pressures
  • Companies have restructured research and development activities to cut costs
  • The industry's most-profitable drugs will continue to lose patent protection
  • Industry Report - Industry Products Chapter

    In 2017, according to the latest available data from QuintilesIMS Health, global generic pharmaceutical sales are expected to account for more than 28.0% of total pharmaceuticals dispensed. By 2022, generic drug sales are anticipated to 29.2% of revenue, partly due to strong demand for generic drugs from emerging markets and the United States, which will increasingly have healthcare providers dispense generic drugs to cut healthcare costs.Furthermore, according to data from the World Health Organization (WHO), demand for generic and brand-name pharmaceuticals varies across lower income countries and middle-income countries. For example, generic pharmaceuticals make up about two-thirds of total pharmaceutical sales in lower income countries, compared with 60.0% i...purchase to read more.

    Additional Insights for the Global Pharmaceuticals & Medicine Manufacturing Industry

    IBISWorld identifies 250 Key Success Factors for a business.The most important for the Global Pharmaceuticals & Medicine Manufacturing Industry are

  • Establishment of brand names
  • Having technology sharing arrangements with major players
  • Undertaking technical research and development
  • IBISWorld analysts also discuss how external factors such as Global number of adults aged 65 and older and Per capita healthcare expenditure of OECD countries in the Global Pharmaceuticals & Medicine Manufacturing industry impact industry performance..

    shopping_cartPURCHASE OPTIONS

    What's in this report

    What is the Global Pharmaceuticals & Medicine Manufacturing Industry?

    This industry comprises companies that manufacture biological, medicinal and pharmaceutical products in various forms, including ampoules, tablets, capsules, vials, ointments, powders, solutions and suspensions. The overall pharmaceutical market can be segmented into prescription-based (or ethical) products and over-the-counter medications. Industry products are predominantly distributed via wholesalers, and are then sold via pharmacies or distributed in hospitals.

    Industry Products
  • Dermatology and antibiotics
  • HIV antivirals and cholesterol
  • Antiulcerants and pain
  • Hypertension and diabetes
  • Oncologics and autoimmune
  • Respiratory health and other CNS
  • Mental health and viral hepatitis
  • Industry Activities
  • Manufacturing patented prescription products
  • Manufacturing generic prescription products
  • Manufacturing over-the-counter products
  • Table of Contents

    Industry Definition
    Main Activities
    Similar Industries
    Additional Resources
    Industry Statistics Snapshot
    Industry Structure
    Executive Summary
    Executive Summary
    Key External Drivers
  • Global number of adults aged 65 and older
  • Per capita healthcare expenditure of OECD countries
  • Regulation for the Global Pharmaceuticals & Medicine Manufacturing industry
  • Technological change for the Global Pharmaceuticals & Medicine Manufacturing industry

  • Current Performance
    Patent cliffChanging structureGlobal trade and regulations
  • Chart: Revenue Growth

  • Industry Outlook
    Patent cliffBiosimilar drugs spur growthGlobal industry landscape
  • Table: Global Pharmaceuticals & Medicine Manufacturing Industry Revenue Outlook

  • Industry Life Cycle
  • Life cycle reasons
  • Chart: Benchmarking - Global Pharmaceuticals & Medicine Manufacturing Industry Lifecycle vs The Economy

  • Supply Chains
    Key Buying Industries
  • Global Wholesale and Retail Trade
  • Global Wholesale Trade
  • Global Health and Social Work
  • Global Consumers

  • Key Selling Industries
  • Global Basic Inorganic Chemicals Manufacturing
  • Global Basic Organic Chemicals Manufacturing
  • Global Biotechnology
  • Global Cosmetics Manufacturing

  • Products & Services
  • Other
  • Oncologics and autoimmune
  • Hypertension and diabetes
  • Antiulcerants and pain
  • Dermatology and antibiotics
  • Mental health and viral hepatitis
  • Respiratory health and other CNS
  • HIV antivirals and cholesterol
  • Chart: Global Pharmaceuticals & Medicine Manufacturing Industry Products and Services Segmentation

  • Demand Determinants
  • Burgeoning elderly population
  • Prevalence of illnesses

  • Major Markets
  • Consumers in developed markets
  • Consumers in pharmerging markets
  • Consumers in the rest of the world (ROW)
  • Chart: Major Market Segmentation for the Global Pharmaceuticals & Medicine Manufacturing Industry

  • International Trade
    Business Locations
    Chart: Business Locations by State
    Market Share Concentration
    Key Success Factors
    Cost Structure Benchmarks
  • Profit
  • Purchases
  • Research and development
  • Other costs
  • Chart: Cost Structure Benchmarking – Sector vs Global Pharmaceuticals & Medicine Manufacturing

  • Basis of Competition
  • Internal competition
  • External competition

  • Barriers to Entry
  • Table: Barrier to Entry Checklist for the Global Pharmaceuticals & Medicine Manufacturing Industry

  • Industry Globalization
    There are no major players in this industry. This report includes analysis of other companies.
    Capital Intensity
  • Chart: Level of Capital Intensity for the Global Pharmaceuticals & Medicine Manufacturing Industry
  • Chart: Tools of the Trade: Growth Strategies for Success

  • Technology & Systems
    Revenue Volatility
  • Chart: Volatility vs Industry Growth

  • Regulation & Policy
    Industry Assistance
    Table: Industry Data for the Global Pharmaceuticals & Medicine Manufacturing Industry
  • Industry Revenue (2008-2022)
  • Industry Gross Product (2008-2022)
  • Establishments (2008-2022)
  • Businesses (2008-2022)
  • Employment (2008-2022)
  • Wages (2008-2022)
  • Per Capita Healthcare Expenditures of OECD Countries (2008-2022)

  • Table: Annual Percentage Change for Key Industry Data
    Table: Key Ratios for Industry Key Data
    Bolt-On Acquisition
  • The acquisition of a company made for the sole purpose of merging it into a division of the acquirer.
  • Contract Manufacturing Organizations (Cmos)
  • Small companies specializing in particular stages or aspects of the R&D process.
  • Generic
  • A medicine based on an active substance that is out of patent and sold under a different name from the originator branded product.
  • Org. For Econ. Co-Operation And Development (Oced)
  • An organization made up of 34 member countries worldwide that regularly turn to one another to identify, discuss and analyze problems and promote policies to solve them.
  • Outsource
  • To procure goods or services under contract with an outside supplier.
  • Over-The-Counter (Otc) Products
  • Products that may be sold to an individual without a prescription from a healthcare professional.
  • Prescription Pharmaceutical
  • A licensed medicine regulated via legislation that may only be dispensed to an individual with a valid prescription from a healthcare professional.
  • Research And Development (R&D)
  • Creative work undertaken by a company in order to increase the stock of knowledge, which can then be applied to developing a new product or improving an existing one.
  • What Our Customers Say

    Why buy this report?

    The global economy presents its own set of opportunities and threats for businesses in a range of industries. IBISWorld’s Global Pharmaceuticals & Medicine Manufacturing global market research report offers insightful industry analysis and research into the market at an international level. IBISWorld’s in-depth industry market research is presented in a logical and consistent format. The industry report contains key industry statistics, market size, industry trends, and growth and profit forecasts for a 5-year outlook period.

    IBISWorld industry market research reports enable you to:
    • Find out about key industry trends
    • Identify threats and opportunities
    • Inform your decisions for marketing, strategy and planning
    • Quickly build competitive intelligence
    This report on Global Pharmaceuticals & Medicine Manufacturing:
    • Provides Market Size information to assist with planning and strategic decisions.
    • Includes the necessary information to perform SWOT, PEST and STEER analysis.
    • Helps you understand market dynamics to give you a deeper understanding of industry competition and the supply chain.
    • Analyses key performance and operational metrics so that you can benchmark against your own business, that of your customers’ businesses, or your competitors’ businesses.
    The Global Pharmaceuticals & Medicine Manufacturing market research report includes:
    • Historical data and analysis for the key drivers of this industry
    • A five-year forecast of the market and noted trends
    • Detailed research and segmentation for the main products and markets
    • An assessment of the competitive landscape and market shares for major companies
    • And of course, much more

    IBISWorld reports on thousands of industries around the world. Our clients rely on our information and data to stay up-to-date on industry trends across all industries. With this IBISWorld Industry Research Report on Global Pharmaceuticals & Medicine Manufacturing, you can expect thoroughly researched, reliable and current information that will help you to make faster, better business decisions.

    Contact Us

    Want to speak to a representative? Call us.